{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T09:43:32Z","timestamp":1790675012722,"version":"4.1.0"},"reference-count":152,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People's Republic of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"FAPESP","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","epilepsybehavior.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy & Behavior"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.yebeh.2025.110396","type":"journal-article","created":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T09:09:04Z","timestamp":1743671344000},"page":"110396","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Tuberous Sclerosis Complex: An updated in the treatment of epilepsy for early careers"],"prefix":"10.1016","volume":"167","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5008-0809","authenticated-orcid":false,"given":"Kette D.","family":"Valente","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leticia Brito","family":"Sampaio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Vincentiis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Lecticia R.","family":"Pinto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Augusta","family":"Montenegro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yebeh.2025.110396_b0005","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1749-6632.1991.tb37754.x","article-title":"Epidemiology of tuberous sclerosis","volume":"615","author":"Osborne","year":"1991","journal-title":"Ann NY Acad Sci"},{"issue":"1","key":"10.1016\/j.yebeh.2025.110396_b0010","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s13023-018-0870-y","article-title":"Incidence of tuberous sclerosis and age at first diagnosis: new data and emerging trends from a national, prospective surveillance study","volume":"13","author":"Ebrahimi-Fakhari","year":"2018","journal-title":"Orphanet J Rare Dis"},{"issue":"11","key":"10.1016\/j.yebeh.2025.110396_b0015","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1005637","article-title":"Mosaic and intronic mutations in TSC1\/TSC2 explain the majority of TSC patients with no mutation identified by conventional testing","volume":"11","author":"Tyburczy","year":"2015","journal-title":"PLoS Genet"},{"key":"10.1016\/j.yebeh.2025.110396_b0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.spen.2023.101086","article-title":"Updated genotype-phenotype correlations in TSC","volume":"47","author":"Curatolo","year":"2023","journal-title":"Semin Pediatr Neurol"},{"key":"10.1016\/j.yebeh.2025.110396_b0025","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ejpn.2023.08.005","article-title":"Updated clinical recommendations for the management of tuberous sclerosis complex associated epilepsy","volume":"47","author":"Specchio","year":"2023","journal-title":"Eur J Paediatr Neurol"},{"key":"10.1016\/j.yebeh.2025.110396_b0030","first-page":"1","article-title":"An overview of the value of mTOR inhibitors to the treatment of epilepsy: the evidence to date","author":"Moloney","year":"2025","journal-title":"Expert Rev Neurother"},{"key":"10.1016\/j.yebeh.2025.110396_b0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2024.110123","article-title":"Evolving treatment strategies for early-life seizures in tuberous sclerosis complex: a review and treatment algorithm","volume":"161","author":"Samanta","year":"2024","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2025.110396_b0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.spen.2024.101155","article-title":"Tuberous sclerosis complex: diagnostic features, surveillance, and therapeutic strategies","volume":"51","author":"Arredondo","year":"2024","journal-title":"Semin Pediatr Neurol"},{"key":"10.1016\/j.yebeh.2025.110396_b0045","doi-asserted-by":"crossref","DOI":"10.1177\/17562864211031100","article-title":"Review of the treatment options for epilepsy in tuberous sclerosis complex: towards precision medicine","volume":"14","author":"Schubert-Bast","year":"2021","journal-title":"Ther Adv Neurol Disord"},{"key":"10.1016\/j.yebeh.2025.110396_b0050","doi-asserted-by":"crossref","first-page":"733","DOI":"10.2147\/NDT.S347327","article-title":"Treatment-resistant epilepsy and tuberous sclerosis complex: treatment, maintenance, and future directions","volume":"19","author":"Singh","year":"2023","journal-title":"Neuropsychiatr Dis Treat"},{"key":"10.1016\/j.yebeh.2025.110396_b0055","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.neuroscience.2016.11.017","article-title":"Molecular neurobiology of mTOR","volume":"341","author":"Switon","year":"2017","journal-title":"Neuroscience"},{"issue":"3","key":"10.1016\/j.yebeh.2025.110396_b0060","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/joa.12956","article-title":"New insights into a spectrum of developmental malformations related to mTOR dysregulations: challenges and perspectives","volume":"235","author":"Muhlebner","year":"2019","journal-title":"J Anat"},{"key":"10.1016\/j.yebeh.2025.110396_b0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2020.105993","article-title":"Natural history of incidental sporadic and tuberous sclerosis complex associated lymphangioleiomyomatosis","volume":"168","author":"Di Marco","year":"2020","journal-title":"Respir Med"},{"issue":"4","key":"10.1016\/j.yebeh.2025.110396_b0070","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.molcel.2012.06.009","article-title":"TBC1D7 is a third subunit of the TSC1-TSC2 complex upstream of mTORC1","volume":"47","author":"Dibble","year":"2012","journal-title":"Mol Cell"},{"key":"10.1016\/j.yebeh.2025.110396_b0075","doi-asserted-by":"crossref","first-page":"16035","DOI":"10.1038\/nrdp.2016.35","article-title":"Tuberous sclerosis complex","volume":"2","author":"Henske","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.yebeh.2025.110396_b0080","doi-asserted-by":"crossref","unstructured":"Man, A., et al., The Genetics of Tuberous Sclerosis Complex and Related mTORopathies: Current Understanding and Future Directions. Genes (Basel), 2024. 15(3).","DOI":"10.3390\/genes15030332"},{"issue":"8","key":"10.1016\/j.yebeh.2025.110396_b0085","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1056\/NEJMcibr1406613","article-title":"Molecular basis of giant cells in tuberous sclerosis complex","volume":"371","author":"Kwiatkowski","year":"2014","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.yebeh.2025.110396_b0090","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.tcb.2015.06.002","article-title":"Regulation of mTORC1 by PI3K signaling","volume":"25","author":"Dibble","year":"2015","journal-title":"Trends Cell Biol"},{"issue":"2","key":"10.1016\/j.yebeh.2025.110396_b0095","doi-asserted-by":"crossref","first-page":"e200","DOI":"10.1212\/WNL.0000000000007749","article-title":"A randomized controlled trial with everolimus for IQ and autism in tuberous sclerosis complex","volume":"93","author":"Overwater","year":"2019","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.yebeh.2025.110396_b0100","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1158\/1541-7786.MCR-14-0343","article-title":"Therapeutic targeting of cellular metabolism in cells with hyperactive mTORC1: a paradigm shift","volume":"13","author":"Medvetz","year":"2015","journal-title":"Mol Cancer Res"},{"key":"10.1016\/j.yebeh.2025.110396_b0105","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.pediatrneurol.2021.07.011","article-title":"Updated international tuberous sclerosis complex diagnostic criteria and surveillance and management recommendations","volume":"123","author":"Northrup","year":"2021","journal-title":"Pediatr Neurol"},{"issue":"4","key":"10.1016\/j.yebeh.2025.110396_b0110","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.pediatrneurol.2013.08.001","article-title":"International tuberous sclerosis complex consensus, tuberous sclerosis complex diagnostic criteria update: recommendations of the 2012 iinternational tuberous sclerosis complex consensus conference","volume":"49","author":"Northrup","year":"2013","journal-title":"Pediatr Neurol"},{"issue":"9","key":"10.1016\/j.yebeh.2025.110396_b0115","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/S1474-4422(20)30220-9","article-title":"Seizure outcome and use of antiepileptic drugs after epilepsy surgery according to histopathological diagnosis: a retrospective multicentre cohort study","volume":"19","author":"Lamberink","year":"2020","journal-title":"Lancet Neurol"},{"issue":"6","key":"10.1016\/j.yebeh.2025.110396_b0120","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.jocn.2013.08.022","article-title":"Natural history and CT scan follow-up of subependymal giant cell tumors in tuberous sclerosis complex patients","volume":"21","author":"Adriaensen","year":"2014","journal-title":"J Clin Neurosci"},{"issue":"1","key":"10.1016\/j.yebeh.2025.110396_b0125","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1186\/s13023-022-02496-2","article-title":"Characterization and management of facial angiofibroma related to tuberous sclerosis complex in the United States: retrospective analysis of the natural history database","volume":"17","author":"Boggarapu","year":"2022","journal-title":"Orphanet J Rare Dis"},{"issue":"8","key":"10.1016\/j.yebeh.2025.110396_b0130","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1111\/j.1651-2227.1996.tb14188.x","article-title":"The natural history of cardiac rhabdomyoma with and without tuberous sclerosis","volume":"85","author":"Bosi","year":"1996","journal-title":"Acta Paediatr"},{"issue":"3","key":"10.1016\/j.yebeh.2025.110396_b0135","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1515\/revneuro-2017-0027","article-title":"The natural history of subependymal giant cell astrocytomas in tuberous sclerosis complex: a review","volume":"29","author":"Chan","year":"2018","journal-title":"Rev Neurosci"},{"issue":"7","key":"10.1016\/j.yebeh.2025.110396_b0140","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1111\/j.1528-1167.2009.02474.x","article-title":"The natural history of epilepsy in tuberous sclerosis complex","volume":"51","author":"Chu-Shore","year":"2010","journal-title":"Epilepsia"},{"issue":"1","key":"10.1016\/j.yebeh.2025.110396_b0145","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1186\/s13023-018-0901-8","article-title":"TSC-associated neuropsychiatric disorders (TAND): findings from the TOSCA natural history study","volume":"13","author":"de Vries","year":"2018","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.yebeh.2025.110396_b0150","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.pediatrneurol.2019.12.016","article-title":"Epilepsy and neurodevelopmental comorbidities in tuberous sclerosis complex: a natural history study","volume":"106","author":"Gupta","year":"2020","journal-title":"Pediatr Neurol"},{"issue":"4","key":"10.1016\/j.yebeh.2025.110396_b0155","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.spen.2015.10.003","article-title":"Natural history and current treatment options for subependymal giant cell astrocytoma in tuberous sclerosis complex","volume":"22","author":"Jozwiak","year":"2015","journal-title":"Semin Pediatr Neurol"},{"issue":"1","key":"10.1016\/j.yebeh.2025.110396_b0160","first-page":"14","article-title":"Natural history of a fibrous cephalic plaque and sustained eight decade follow-up in an 80 year old with tuberous sclerosis complex type 2","volume":"89","author":"Kirk","year":"2020","journal-title":"Ulster Med J"},{"issue":"731","key":"10.1016\/j.yebeh.2025.110396_b0165","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1259\/0007-1285-61-731-1074","article-title":"The natural history of renal cysts in an infant with tuberous sclerosis: evaluation with ultrasound","volume":"61","author":"Moss","year":"1988","journal-title":"Br J Radiol"},{"issue":"7","key":"10.1016\/j.yebeh.2025.110396_b0170","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1080\/03007995.2017.1313726","article-title":"Natural history of patients with tuberous sclerosis complex related renal angiomyolipoma","volume":"33","author":"Song","year":"2017","journal-title":"Curr Med Res Opin"},{"issue":"10","key":"10.1016\/j.yebeh.2025.110396_b0175","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1001\/jamadermatol.2014.938","article-title":"Dermatologic and dental aspects of the 2012 international tuberous sclerosis complex consensus statements","volume":"150","author":"Teng","year":"2014","journal-title":"JAMA Dermatol"},{"issue":"10","key":"10.1016\/j.yebeh.2025.110396_b0180","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.braindev.2015.04.003","article-title":"Age-related changes of susceptibility-weighted imaging in subependymal nodules of neonates and children with tuberous sclerosis complex","volume":"37","author":"Niwa","year":"2015","journal-title":"Brain and Development"},{"issue":"9","key":"10.1016\/j.yebeh.2025.110396_b0185","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1136\/adc.2007.125880","article-title":"Subependymal nodules, giant cell astrocytomas and the tuberous sclerosis complex: a population-based study","volume":"93","author":"O'Callaghan","year":"2008","journal-title":"Arch Dis Child"},{"issue":"2","key":"10.1016\/j.yebeh.2025.110396_b0190","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s00381-012-1892-8","article-title":"Subependymal nodules and giant cell tumours in tuberous sclerosis complex patients: prevalence on MRI in relation to gene mutation","volume":"29","author":"Michelozzi","year":"2013","journal-title":"Childs Nerv Syst"},{"issue":"4","key":"10.1016\/j.yebeh.2025.110396_b0195","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/s00381-017-3335-z","article-title":"Unique findings of subependymal giant cell astrocytoma within cortical tubers in patients with tuberous sclerosis complex: a histopathological evaluation","volume":"33","author":"Katz","year":"2017","journal-title":"Childs Nerv Syst"},{"issue":"12","key":"10.1016\/j.yebeh.2025.110396_b0200","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1007\/s00381-013-2170-0","article-title":"Successful everolimus therapy for SEGA in pediatric patients with tuberous sclerosis complex","volume":"29","author":"Cappellano","year":"2013","journal-title":"Childs Nerv Syst"},{"issue":"3","key":"10.1016\/j.yebeh.2025.110396_b0205","first-page":"315","article-title":"Surgical timing of the subependymal giant cell astrocytoma (SEGA) with the patients of tuberous sclerosis complex","volume":"21","author":"Ekici","year":"2011","journal-title":"Turk Neurosurg"},{"key":"10.1016\/j.yebeh.2025.110396_b0210","unstructured":"Program, B.C.s.H.T.; Available from: childrenshospital.org."},{"key":"10.1016\/j.yebeh.2025.110396_b0215","unstructured":"Checklist, T.C. 2025; Available from: https:\/\/tandconsortium.org\/checklists\/."},{"key":"10.1016\/j.yebeh.2025.110396_b0220","first-page":"603","article-title":"Tuberous sclerosis complex-associated neuropsychiatric disorders (TAND): new findings on age, sex, and genotype in relation to intellectual phenotype","volume":"11","author":"de Vries","year":"2020","journal-title":"Front Neurol"},{"issue":"1","key":"10.1016\/j.yebeh.2025.110396_b0225","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1186\/s13023-020-01488-4","article-title":"The TAND checklist: a useful screening tool in children with tuberous sclerosis and neurofibromatosis type 1","volume":"15","author":"Cervi","year":"2020","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"10.1016\/j.yebeh.2025.110396_b0230","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s11689-020-09327-0","article-title":"Natural clusters of tuberous sclerosis complex (TSC)-associated neuropsychiatric disorders (TAND): new findings from the TOSCA TAND research project","volume":"12","author":"de Vries","year":"2020","journal-title":"J Neurodev Disord"},{"issue":"1","key":"10.1016\/j.yebeh.2025.110396_b0235","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s11689-023-09500-1","article-title":"International consensus recommendations for the identification and treatment of tuberous sclerosis complex-associated neuropsychiatric disorders (TAND)","volume":"15","author":"de Vries","year":"2023","journal-title":"J Neurodev Disord"},{"issue":"1","key":"10.1016\/j.yebeh.2025.110396_b0240","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.pediatrneurol.2014.10.006","article-title":"Pilot validation of the tuberous sclerosis-associated neuropsychiatric disorders (TAND) checklist","volume":"52","author":"Leclezio","year":"2015","journal-title":"Pediatr Neurol"},{"issue":"4","key":"10.1016\/j.yebeh.2025.110396_b0245","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.spen.2015.10.002","article-title":"Genotype\/phenotype correlations in tuberous sclerosis complex","volume":"22","author":"Curatolo","year":"2015","journal-title":"Semin Pediatr Neurol"},{"issue":"1","key":"10.1016\/j.yebeh.2025.110396_b0250","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/epi4.12286","article-title":"Epilepsy in tuberous sclerosis complex: findings from the TOSCA Study","volume":"4","author":"Nabbout","year":"2019","journal-title":"Epilepsia Open"},{"issue":"2","key":"10.1016\/j.yebeh.2025.110396_b0255","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.ejpn.2015.12.005","article-title":"Early onset epileptic encephalopathy or genetically determined encephalopathy with early onset epilepsy? Lessons learned from TSC","volume":"20","author":"Curatolo","year":"2016","journal-title":"Eur J Paediatr Neurol"},{"issue":"14","key":"10.1016\/j.yebeh.2025.110396_b0260","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1177\/0883073817737446","article-title":"Predictors of drug-resistant epilepsy in tuberous sclerosis complex","volume":"32","author":"Jeong","year":"2017","journal-title":"J Child Neurol"},{"issue":"3","key":"10.1016\/j.yebeh.2025.110396_b0265","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1111\/epi.16815","article-title":"The ILAE classification of seizures and the epilepsies: Modification for seizures in the neonate. Position paper by the ILAE Task Force on Neonatal Seizures","volume":"62","author":"Pressler","year":"2021","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2025.110396_b0270","unstructured":"Avanzini, G.S., G.; Canafoglia, L.; Franceschetti, S., Maturation of cortical physiological properties relevant to epileptogenesis, in Abnormal cortical development and epilepsy, R.A. Spreafico, G.; Andermann, F.; editors, Editor. 1999, John-Libbey and Company: London. p. 63-75."},{"key":"10.1016\/j.yebeh.2025.110396_b0275","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.pediatrneurol.2024.06.012","article-title":"Drug-resistant epilepsy in tuberous sclerosis complex is associated with TSC2 genotype: more findings from the preventing epilepsy using vigatrin (PREVeNT) trial","volume":"159","author":"Farach","year":"2024","journal-title":"Pediatr Neurol"},{"issue":"Pt A","key":"10.1016\/j.yebeh.2025.110396_b0280","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.yebeh.2017.02.007","article-title":"Influence of seizures on early development in tuberous sclerosis complex","volume":"70","author":"Capal","year":"2017","journal-title":"Epilepsy Behav"},{"issue":"5","key":"10.1016\/j.yebeh.2025.110396_b0285","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1111\/epi.16892","article-title":"Early epileptiform EEG activity in infants with tuberous sclerosis complex predicts epilepsy and neurodevelopmental outcomes","volume":"62","author":"De Ridder","year":"2021","journal-title":"Epilepsia"},{"issue":"5","key":"10.1016\/j.yebeh.2025.110396_b0290","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1111\/epi.17199","article-title":"Time to onset of cannabidiol treatment effect and resolution of adverse events in tuberous sclerosis complex: Post hoc analysis of randomized controlled phase 3 trial GWPCARE6","volume":"63","author":"Wu","year":"2022","journal-title":"Epilepsia"},{"issue":"9","key":"10.1016\/j.yebeh.2025.110396_b0295","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1111\/epi.13467","article-title":"Systemic disease manifestations associated with epilepsy in tuberous sclerosis complex","volume":"57","author":"Jeong","year":"2016","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2025.110396_b0300","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2021.697467","article-title":"Historical patterns of diagnosis, treatments, and outcome of epilepsy associated with tuberous sclerosis complex: results from TOSCA registry","volume":"12","author":"Nabbout","year":"2021","journal-title":"Front Neurol"},{"issue":"9","key":"10.1016\/j.yebeh.2025.110396_b0305","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1038\/s41436-020-0823-4","article-title":"TSC2 pathogenic variants are predictive of severe clinical manifestations in TSC infants: results of the EPISTOP study","volume":"22","author":"Ogorek","year":"2020","journal-title":"Genet Med"},{"key":"10.1016\/j.yebeh.2025.110396_b0310","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.eplepsyres.2018.09.016","article-title":"High vigabatrin dosage is associated with lower risk of infantile spasms relapse among children with tuberous sclerosis complex","volume":"148","author":"Hussain","year":"2018","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2025.110396_b0315","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2020.107624","article-title":"Potential induction of epileptic spasms by nonselective voltage-gated sodium channel blockade: Interaction with etiology","volume":"115","author":"Hussain","year":"2021","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2025.110396_b0320","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.pediatrneurol.2024.09.023","article-title":"Cenobamate's efficacy for seizure treatment in tuberous sclerosis complex","volume":"161","author":"Aungaroon","year":"2024","journal-title":"Pediatr Neurol"},{"issue":"8685","key":"10.1016\/j.yebeh.2025.110396_b0325","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/0140-6736(90)90660-W","article-title":"Vigabatrin in infantile spasms","volume":"335","author":"Chiron","year":"1990","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.yebeh.2025.110396_b0330","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1111\/j.1528-1157.1996.tb00627.x","article-title":"Vigabatrin as initial therapy for infantile spasms: a European retrospective survey. Sabril IS Investigator and Peer Review Groups","volume":"37","author":"Aicardi","year":"1996","journal-title":"Epilepsia"},{"issue":"2","key":"10.1016\/j.yebeh.2025.110396_b0335","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S0920-1211(96)01006-6","article-title":"Randomized trial comparing vigabatrin and hydrocortisone in infantile spasms due to tuberous sclerosis","volume":"26","author":"Chiron","year":"1997","journal-title":"Epilepsy Res"},{"issue":"3","key":"10.1016\/j.yebeh.2025.110396_b0340","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1177\/0883073812446485","article-title":"Vigabatrin and mental retardation in tuberous sclerosis: infantile spasms versus focal seizures","volume":"28","author":"Yum","year":"2013","journal-title":"J Child Neurol"},{"issue":"11","key":"10.1016\/j.yebeh.2025.110396_b0345","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1177\/0883073810365103","article-title":"Vigabatrin for the treatment of infantile spasms: final report of a randomized trial","volume":"25","author":"Elterman","year":"2010","journal-title":"J Child Neurol"},{"issue":"8","key":"10.1016\/j.yebeh.2025.110396_b0350","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1212\/WNL.57.8.1416","article-title":"Randomized trial of vigabatrin in patients with infantile spasms","volume":"57","author":"Elterman","year":"2001","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.yebeh.2025.110396_b0355","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/dmcn.12573","article-title":"Does vigabatrin treatment for infantile spasms cause visual field defects? An international multicentre study","volume":"57","author":"Riikonen","year":"2015","journal-title":"Dev Med Child Neurol"},{"issue":"5","key":"10.1016\/j.yebeh.2025.110396_b0360","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1177\/08830738211048326","article-title":"Focal epilepsy in children with tuberous sclerosis complex: does vigabatrin control focal seizures?","volume":"37","author":"Lin","year":"2022","journal-title":"J Child Neurol"},{"issue":"4","key":"10.1016\/j.yebeh.2025.110396_b0365","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaapos.2022.05.001","article-title":"Ocular examinations, findings, and toxicity in children taking vigabatrin","volume":"26","author":"Schein","year":"2022","journal-title":"J AAPOS"},{"issue":"5","key":"10.1016\/j.yebeh.2025.110396_b0370","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1111\/dmcn.15099","article-title":"Visual field defects after vigabatrin treatment during infancy: retrospective population-based study","volume":"64","author":"Jonsson","year":"2022","journal-title":"Dev Med Child Neurol"},{"issue":"7","key":"10.1016\/j.yebeh.2025.110396_b0375","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1111\/j.1528-1167.2008.01589.x","article-title":"Vigabatrin in the treatment of childhood epilepsy: a retrospective chart review of efficacy and safety profile","volume":"49","author":"Camposano","year":"2008","journal-title":"Epilepsia"},{"issue":"2","key":"10.1016\/j.yebeh.2025.110396_b0380","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/epi.18190","article-title":"Vigabatrin-associated brain magnetic resonance imaging abnormalities and clinical symptoms in infants with tuberous sclerosis complex","volume":"66","author":"Stevering","year":"2025","journal-title":"Epilepsia"},{"issue":"4","key":"10.1016\/j.yebeh.2025.110396_b0385","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.yebeh.2011.08.037","article-title":"Long-term neurological outcome in children with early-onset epilepsy associated with tuberous sclerosis","volume":"22","author":"Cusmai","year":"2011","journal-title":"Epilepsy Behav"},{"issue":"3","key":"10.1016\/j.yebeh.2025.110396_b0390","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1001\/jamaneurol.2020.4607","article-title":"Add-on cannabidiol treatment for drug-resistant seizures in tuberous sclerosis complex: a placebo-controlled randomized clinical trial","volume":"78","author":"Thiele","year":"2021","journal-title":"JAMA Neurol"},{"issue":"2","key":"10.1016\/j.yebeh.2025.110396_b0395","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1111\/epi.17150","article-title":"Long-term cannabidiol treatment for seizures in patients with tuberous sclerosis complex: an open-label extension trial","volume":"63","author":"Thiele","year":"2022","journal-title":"Epilepsia"},{"issue":"1","key":"10.1016\/j.yebeh.2025.110396_b0400","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s12888-023-05422-3","article-title":"Cannabidiol (Epidyolex(R)) for severe behavioral manifestations in patients with tuberous sclerosis complex, mucopolysaccharidosis type III and fragile X syndrome: protocol for a series of randomized, placebo-controlled N-of-1 trials","volume":"24","author":"Muller","year":"2024","journal-title":"BMC Psychiatry"},{"issue":"9","key":"10.1016\/j.yebeh.2025.110396_b0405","doi-asserted-by":"crossref","DOI":"10.3390\/biom14091190","article-title":"Therapeutic approaches to tuberous sclerosis complex: from available therapies to promising drug targets","volume":"14","author":"Conte","year":"2024","journal-title":"Biomolecules"},{"issue":"7","key":"10.1016\/j.yebeh.2025.110396_b0410","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/s41594-019-0245-7","article-title":"Structures of human ENT1 in complex with adenosine reuptake inhibitors","volume":"26","author":"Wright","year":"2019","journal-title":"Nat Struct Mol Biol"},{"issue":"10056","key":"10.1016\/j.yebeh.2025.110396_b0415","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1016\/S0140-6736(16)31419-2","article-title":"Adjunctive everolimus therapy for treatment-resistant focal-onset seizures associated with tuberous sclerosis (EXIST-3): a phase 3, randomised, double-blind, placebo-controlled study","volume":"388","author":"French","year":"2016","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.yebeh.2025.110396_b0420","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/S2352-4642(18)30099-3","article-title":"Adjunctive everolimus for children and adolescents with treatment-refractory seizures associated with tuberous sclerosis complex: post-hoc analysis of the phase 3 EXIST-3 trial","volume":"2","author":"Curatolo","year":"2018","journal-title":"Lancet Child Adolesc Health"},{"key":"10.1016\/j.yebeh.2025.110396_b0425","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2021.630378","article-title":"TuberOus sclerosis registry to increase disease awareness (TOSCA) post-authorisation safety study of everolimus in patients with tuberous sclerosis complex","volume":"12","author":"Kingswood","year":"2021","journal-title":"Front Neurol"},{"issue":"6","key":"10.1016\/j.yebeh.2025.110396_b0430","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1111\/epi.14085","article-title":"Everolimus dosing recommendations for tuberous sclerosis complex-associated refractory seizures","volume":"59","author":"Franz","year":"2018","journal-title":"Epilepsia"},{"issue":"3","key":"10.1016\/j.yebeh.2025.110396_b0435","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1111\/epi.16829","article-title":"Everolimus in adult tuberous sclerosis complex patients with epilepsy: too late for success? A retrospective study","volume":"62","author":"Stockinger","year":"2021","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2025.110396_b0440","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2022.704978","article-title":"Antiepileptic effect and safety profile of rapamycin in pediatric patients with tuberous sclerosis complex","volume":"13","author":"Sadowski","year":"2022","journal-title":"Front Neurol"},{"issue":"32","key":"10.1016\/j.yebeh.2025.110396_b0445","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000039244","article-title":"Pharmacokinetic variability of everolimus and impact of concomitant antiseizure medications in patients with tuberous sclerosis complex: a retrospective study of therapeutic drug monitoring data in Denmark and Norway","volume":"103","author":"Kirkeby","year":"2024","journal-title":"Med (Baltimore)"},{"issue":"6","key":"10.1016\/j.yebeh.2025.110396_b0450","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1093\/ndt\/gfu013","article-title":"The effect of everolimus on renal angiomyolipoma in patients with tuberous sclerosis complex being treated for subependymal giant cell astrocytoma: subgroup results from the randomized, placebo-controlled, Phase 3 trial EXIST-1","volume":"29","author":"Kingswood","year":"2014","journal-title":"Nephrol Dial Transplant"},{"issue":"6","key":"10.1016\/j.yebeh.2025.110396_b0455","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0158476","article-title":"Long-term use of everolimus in patients with tuberous sclerosis complex: final results from the EXIST-1 study","volume":"11","author":"Franz","year":"2016","journal-title":"PLoS One"},{"issue":"9869","key":"10.1016\/j.yebeh.2025.110396_b0460","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S0140-6736(12)61767-X","article-title":"Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial","volume":"381","author":"Bissler","year":"2013","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.yebeh.2025.110396_b0465","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1111\/jdv.14964","article-title":"Effect of everolimus on skin lesions in patients treated for subependymal giant cell astrocytoma and renal angiomyolipoma: final 4-year results from the randomized EXIST-1 and EXIST-2 studies","volume":"32","author":"Franz","year":"2018","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"10","key":"10.1016\/j.yebeh.2025.110396_b0470","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1111\/j.1528-1167.2005.00266.x","article-title":"Tuberous sclerosis complex and the ketogenic diet","volume":"46","author":"Kossoff","year":"2005","journal-title":"Epilepsia"},{"issue":"1","key":"10.1016\/j.yebeh.2025.110396_b0475","doi-asserted-by":"crossref","first-page":"45","DOI":"10.14581\/jer.17008","article-title":"Ketogenic diet for the management of epilepsy associated with tuberous sclerosis complex in children","volume":"7","author":"Park","year":"2017","journal-title":"J Epilepsy Res"},{"key":"10.1016\/j.yebeh.2025.110396_b0480","doi-asserted-by":"crossref","DOI":"10.1016\/j.eplepsyres.2020.106348","article-title":"Long-term outcomes of ketogenic diet in patients with tuberous sclerosis complex-derived epilepsy","volume":"164","author":"Youn","year":"2020","journal-title":"Epilepsy Res"},{"issue":"10","key":"10.1016\/j.yebeh.2025.110396_b0485","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1007\/s00381-020-04715-2","article-title":"Epilepsy surgery in tuberous sclerosis complex (TSC): emerging techniques and redefinition of treatment goals","volume":"36","author":"Treiber","year":"2020","journal-title":"Childs Nerv Syst"},{"issue":"4","key":"10.1016\/j.yebeh.2025.110396_b0490","doi-asserted-by":"crossref","first-page":"E5","DOI":"10.3171\/2022.7.FOCUS22335","article-title":"Comparison of outcomes after stereoelectroencephalography and subdural grid monitoring in pediatric tuberous sclerosis complex","volume":"53","author":"Larrew","year":"2022","journal-title":"Neurosurg Focus"},{"key":"10.1016\/j.yebeh.2025.110396_b0495","doi-asserted-by":"crossref","DOI":"10.1016\/j.eplepsyres.2024.107422","article-title":"Impact of seizure onset zone and intracranial electroencephalography ictal characteristics on epilepsy surgery outcomes in tuberous sclerosis complex","volume":"205","author":"Miecznikowski","year":"2024","journal-title":"Epilepsy Res"},{"issue":"5S","key":"10.1016\/j.yebeh.2025.110396_b0500","article-title":"Overview of therapeutic options for epilepsy","volume":"29","author":"Kuchenbuch","year":"2022","journal-title":"Arch Pediatr"},{"issue":"4","key":"10.1016\/j.yebeh.2025.110396_b0505","doi-asserted-by":"crossref","first-page":"384","DOI":"10.3171\/2024.4.PEDS2481","article-title":"Association of earlier surgery with improved postoperative language development in children with tuberous sclerosis complex","volume":"34","author":"Sadeghzadeh","year":"2024","journal-title":"J Neurosurg Pediatr"},{"issue":"9","key":"10.1016\/j.yebeh.2025.110396_b0510","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1111\/j.1528-1157.2000.tb00327.x","article-title":"Epilepsy surgery in children with tuberous sclerosis complex: presurgical evaluation and outcome","volume":"41","author":"Koh","year":"2000","journal-title":"Epilepsia"},{"issue":"4","key":"10.1016\/j.yebeh.2025.110396_b0515","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.pediatrneurol.2004.05.012","article-title":"Epilepsy surgery for tuberous sclerosis","volume":"31","author":"Romanelli","year":"2004","journal-title":"Pediatr Neurol"},{"issue":"5","key":"10.1016\/j.yebeh.2025.110396_b0520","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.pediatrneurol.2010.01.001","article-title":"Tuberous sclerosis complex with a single brain lesion on MRI mimicking focal cortical dysplasia","volume":"42","author":"Hirfanoglu","year":"2010","journal-title":"Pediatr Neurol"},{"issue":"11","key":"10.1016\/j.yebeh.2025.110396_b0525","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1111\/epi.12371","article-title":"Predictors of seizure-free outcome after epilepsy surgery for pediatric tuberous sclerosis complex","volume":"54","author":"Krsek","year":"2013","journal-title":"Epilepsia"},{"issue":"1","key":"10.1016\/j.yebeh.2025.110396_b0530","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1684\/epd.2021.1253","article-title":"Surgery for drug-resistant tuberous sclerosis complex-associated epilepsy: who, when, and what","volume":"23","author":"Specchio","year":"2021","journal-title":"Epileptic Disord"},{"issue":"2","key":"10.1016\/j.yebeh.2025.110396_b0535","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1093\/brain\/awz411","article-title":"Resective epilepsy surgery in tuberous sclerosis complex: a nationwide multicentre retrospective study from China","volume":"143","author":"Liu","year":"2020","journal-title":"Brain"},{"issue":"23","key":"10.1016\/j.yebeh.2025.110396_b0540","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1212\/WNL.0b013e3182768923","article-title":"Intrinsic epileptogenicity of cortical tubers revealed by intracranial EEG monitoring","volume":"79","author":"Mohamed","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2025.110396_b0545","doi-asserted-by":"crossref","DOI":"10.1016\/j.eplepsyres.2021.106572","article-title":"Resection of tuber centers only for seizure control in tuberous sclerosis complex","volume":"171","author":"Stephenson","year":"2021","journal-title":"Epilepsy Res"},{"issue":"4","key":"10.1016\/j.yebeh.2025.110396_b0550","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1227\/NEU.0000000000000875","article-title":"Resective epilepsy surgery for tuberous sclerosis in children: determining predictors of seizure outcomes in a multicenter retrospective cohort study","volume":"77","author":"Fallah","year":"2015","journal-title":"Neurosurgery"},{"issue":"6","key":"10.1016\/j.yebeh.2025.110396_b0555","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0157396","article-title":"Novel histopathological patterns in cortical tubers of epilepsy surgery patients with tuberous sclerosis complex","volume":"11","author":"Muhlebner","year":"2016","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.yebeh.2025.110396_b0560","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1007\/s00415-010-5535-2","article-title":"MRI findings reveal three different types of tubers in patients with tuberous sclerosis complex","volume":"257","author":"Gallagher","year":"2010","journal-title":"J Neurol"},{"issue":"1","key":"10.1016\/j.yebeh.2025.110396_b0565","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/epi.16410","article-title":"Epileptogenicity in tuberous sclerosis complex: a stereoelectroencephalographic study","volume":"61","author":"Neal","year":"2020","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2025.110396_b0570","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2021.117506","article-title":"Seizure outcome after epilepsy surgery in tuberous sclerosis complex: results and analysis of predictors from a multicenter study","volume":"427","author":"Vannicola","year":"2021","journal-title":"J Neurol Sci"},{"issue":"8","key":"10.1016\/j.yebeh.2025.110396_b0575","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.neurol.2024.04.009","article-title":"Pathways to epilepsy surgery in children with tuberous sclerosis complex-associated epilepsy","volume":"180","author":"Gauer","year":"2024","journal-title":"Rev Neurol (Paris)"},{"issue":"3","key":"10.1016\/j.yebeh.2025.110396_b0580","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.neurol.2018.11.002","article-title":"Resective surgery in tuberous sclerosis complex, from penfield to 2018: a critical review","volume":"175","author":"Ostrowsky-Coste","year":"2019","journal-title":"Rev Neurol (Paris)"},{"issue":"1","key":"10.1016\/j.yebeh.2025.110396_b0585","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1007\/s00701-024-06238-0","article-title":"MR-guided laser interstitial thermal therapy in the treatment of brain tumors and epilepsy","volume":"166","author":"Nielsen","year":"2024","journal-title":"Acta Neurochir (Wien)"},{"issue":"8","key":"10.1016\/j.yebeh.2025.110396_b0590","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1007\/s00381-019-04255-4","article-title":"\u201cLaser and the Tuber\u201d: thermal dynamic and volumetric factors influencing seizure outcomes in pediatric subjects with tuberous sclerosis undergoing stereoencephalography-directed laser ablation of tubers","volume":"35","author":"Stellon","year":"2019","journal-title":"Childs Nerv Syst"},{"issue":"3","key":"10.1016\/j.yebeh.2025.110396_b0595","doi-asserted-by":"crossref","first-page":"E9","DOI":"10.3171\/2018.6.FOCUS18228","article-title":"Single and staged laser interstitial thermal therapy ablation for cortical tubers causing refractory epilepsy in pediatric patients","volume":"45","author":"Tovar-Spinoza","year":"2018","journal-title":"Neurosurg Focus"},{"issue":"4","key":"10.1016\/j.yebeh.2025.110396_b0600","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.yebeh.2012.04.135","article-title":"MR-guided stereotactic laser ablation of epileptogenic foci in children","volume":"24","author":"Curry","year":"2012","journal-title":"Epilepsy Behav"},{"issue":"9","key":"10.1016\/j.yebeh.2025.110396_b0605","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s11910-017-0772-8","article-title":"Laser interstitial thermal therapy for epilepsy","volume":"17","author":"Prince","year":"2017","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"10","key":"10.1016\/j.yebeh.2025.110396_b0610","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1007\/s00381-016-3193-0","article-title":"MRI-guided laser interstitial thermal therapy for the treatment of low-grade gliomas in children: a case-series review, description of the current technologies and perspectives","volume":"32","author":"Tovar-Spinoza","year":"2016","journal-title":"Childs Nerv Syst"},{"issue":"1","key":"10.1016\/j.yebeh.2025.110396_b0615","doi-asserted-by":"crossref","first-page":"92","DOI":"10.3171\/2018.6.PEDS1828","article-title":"MRI-guided laser interstitial thermal therapy in an infant with tuberous sclerosis: technical case report","volume":"23","author":"Hooten","year":"2019","journal-title":"J Neurosurg Pediatr"},{"issue":"5","key":"10.1016\/j.yebeh.2025.110396_b0620","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1212\/WNL.51.5.1263","article-title":"Surgical treatment of epilepsy in tuberous sclerosis: strategies and results in 18 patients","volume":"51","author":"Guerreiro","year":"1998","journal-title":"Neurology"},{"issue":"Pt A","key":"10.1016\/j.yebeh.2025.110396_b0625","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.yebeh.2019.06.007","article-title":"Corpus callosotomy for drug-resistant spasms associated with tuberous sclerosis complex","volume":"98","author":"Okanishi","year":"2019","journal-title":"Epilepsy Behav"},{"issue":"19","key":"10.1016\/j.yebeh.2025.110396_b0630","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1212\/WNL.0000000000003307","article-title":"Selective posterior callosotomy for drop attacks: a new approach sparing prefrontal connectivity","volume":"87","author":"Paglioli","year":"2016","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.yebeh.2025.110396_b0635","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.pediatrneurol.2010.03.003","article-title":"Vagus nerve stimulation for refractory epilepsy in tuberous sclerosis","volume":"43","author":"Zamponi","year":"2010","journal-title":"Pediatr Neurol"},{"issue":"3","key":"10.1016\/j.yebeh.2025.110396_b0640","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.yebeh.2009.08.018","article-title":"Refractory epilepsy in tuberous sclerosis: vagus nerve stimulation with or without subsequent resective surgery","volume":"16","author":"Elliott","year":"2009","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2025.110396_b0645","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.pediatrneurol.2023.05.008","article-title":"Responsive neurostimulation for the treatment of children with drug-resistant epilepsy in tuberous sclerosis complex","volume":"145","author":"Karakas","year":"2023","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.yebeh.2025.110396_b0650","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2024.110067","article-title":"Neuromodulation strategies in developmental and epileptic encephalopathies","volume":"160","author":"Samanta","year":"2024","journal-title":"Epilepsy Behav"},{"issue":"2","key":"10.1016\/j.yebeh.2025.110396_b0655","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1002\/epi4.12481","article-title":"Brain-Responsive Neurostimulation for the treatment of adults with epilepsy in tuberous sclerosis complex: a case series","volume":"6","author":"McDermott","year":"2021","journal-title":"Epilepsia Open"},{"issue":"6","key":"10.1016\/j.yebeh.2025.110396_b0660","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1111\/epi.17243","article-title":"Neurostimulation in people with drug-resistant epilepsy: systematic review and meta-analysis from the ILAE surgical therapies commission","volume":"63","author":"Touma","year":"2022","journal-title":"Epilepsia"},{"issue":"5","key":"10.1016\/j.yebeh.2025.110396_b0665","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.ejpn.2011.03.010","article-title":"Antiepileptic treatment before the onset of seizures reduces epilepsy severity and risk of mental retardation in infants with tuberous sclerosis complex","volume":"15","author":"Jozwiak","year":"2011","journal-title":"Eur J Paediatr Neurol"},{"issue":"2","key":"10.1016\/j.yebeh.2025.110396_b0670","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/ana.25956","article-title":"Prevention of epilepsy in infants with tuberous sclerosis complex in the EPISTOP trial","volume":"89","author":"Kotulska","year":"2021","journal-title":"Ann Neurol"},{"key":"10.1016\/j.yebeh.2025.110396_b0675","article-title":"Early treatment with vigabatrin does not decrease focal seizures or improve cognition in tuberous sclerosis complex: the PREVeNT trial","author":"Bebin","year":"2023","journal-title":"Ann Neurol"},{"key":"10.1016\/j.yebeh.2025.110396_b0680","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pediatrneurol.2021.06.012","article-title":"Epilepsy is heterogeneous in early-life tuberous sclerosis complex","volume":"123","author":"Ihnen","year":"2021","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.yebeh.2025.110396_b0685","article-title":"Commentary Regarding the results of the PREVeNT and EPISTOP trials","author":"Jozwiak","year":"2023","journal-title":"Ann Neurol"},{"issue":"1","key":"10.1016\/j.yebeh.2025.110396_b0690","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S1474-4422(16)30294-0","article-title":"Safety and effectiveness of hormonal treatment versus hormonal treatment with vigabatrin for infantile spasms (ICISS): a randomised, multicentre, open-label trial","volume":"16","author":"O'Callaghan","year":"2017","journal-title":"Lancet Neurol"},{"issue":"21","key":"10.1016\/j.yebeh.2025.110396_b0695","doi-asserted-by":"crossref","DOI":"10.3390\/jcm13216335","article-title":"Prenatal mTOR inhibitors in tuberous sclerosis complex: current insights and future directions","volume":"13","author":"Racioppi","year":"2024","journal-title":"J Clin Med"},{"issue":"1","key":"10.1016\/j.yebeh.2025.110396_b0700","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s13023-024-03495-1","volume":"20","author":"Driedger","year":"2025","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.yebeh.2025.110396_b0705","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpeds.2021.02.060","article-title":"Fetal brain magnetic resonance imaging findings predict neurodevelopment in children with tuberous sclerosis complex","volume":"233","author":"Hulshof","year":"2021","journal-title":"J Pediatr"},{"issue":"1","key":"10.1016\/j.yebeh.2025.110396_b0710","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.acra.2011.08.016","article-title":"Loss of white matter microstructural integrity is associated with adverse neurological outcome in tuberous sclerosis complex","volume":"19","author":"Peters","year":"2012","journal-title":"Acad Radiol"},{"issue":"6","key":"10.1016\/j.yebeh.2025.110396_b0715","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1080\/17512433.2021.1911643","article-title":"Prescription patterns of antiseizure drugs in tuberous sclerosis complex (TSC)-associated epilepsy: a multicenter cohort study from Germany and review of the literature","volume":"14","author":"Strzelczyk","year":"2021","journal-title":"Expert Rev Clin Pharmacol"},{"issue":"11","key":"10.1016\/j.yebeh.2025.110396_b0720","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1080\/13696998.2016.1199432","article-title":"The economic burden of tuberous sclerosis complex in the UK: a retrospective cohort study in the clinical practice research datalink","volume":"19","author":"Kingswood","year":"2016","journal-title":"J Med Econ"},{"issue":"10","key":"10.1016\/j.yebeh.2025.110396_b0725","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-015236","article-title":"Understanding the health economic burden of patients with tuberous sclerosis complex (TSC) with epilepsy: a retrospective cohort study in the UK Clinical Practice Research Datalink (CPRD)","volume":"7","author":"Shepherd","year":"2017","journal-title":"BMJ Open"},{"key":"10.1016\/j.yebeh.2025.110396_b0730","doi-asserted-by":"crossref","first-page":"904","DOI":"10.3389\/fneur.2020.00904","article-title":"Burden of illness and quality of life in tuberous sclerosis complex: findings from the TOSCA study","volume":"11","author":"Jansen","year":"2020","journal-title":"Front Neurol"},{"issue":"1","key":"10.1016\/j.yebeh.2025.110396_b0735","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s42466-021-00130-3","article-title":"Quality of life and its predictors in adults with tuberous sclerosis complex (TSC): a multicentre cohort study from Germany","volume":"3","author":"Zollner","year":"2021","journal-title":"Neurol Res Pract"},{"issue":"3","key":"10.1016\/j.yebeh.2025.110396_b0740","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1111\/j.1528-1167.2006.00956.x","article-title":"The Liverpool adverse events profile: relation to AED use and mood","volume":"48","author":"Panelli","year":"2007","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2025.110396_b0745","unstructured":"Alliance, T. 2025; Available from: tscalliance.org."},{"key":"10.1016\/j.yebeh.2025.110396_b0750","unstructured":"Tuberous Sclerosis Complex Autism Center of Excellence, N., 2025."},{"key":"10.1016\/j.yebeh.2025.110396_b0755","unstructured":"(NINDS), N.I.o.N.D.a.S., acessed March 1st, 2025."},{"key":"10.1016\/j.yebeh.2025.110396_b0760","doi-asserted-by":"crossref","DOI":"10.1111\/epi.18209","article-title":"The epilepsy-autism phenotype associated with developmental and epileptic encephalopathies: new mechanism-based therapeutic options","author":"Specchio","year":"2025","journal-title":"Epilepsia"}],"container-title":["Epilepsy & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505025001350?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505025001350?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T23:00:42Z","timestamp":1745535642000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525505025001350"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":152,"alternative-id":["S1525505025001350"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2025.110396","relation":{},"ISSN":["1525-5050"],"issn-type":[{"value":"1525-5050","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tuberous Sclerosis Complex: An updated in the treatment of epilepsy for early careers","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yebeh.2025.110396","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110396"}}